灌流細胞培養

上流の連続バイオプロセシングの基礎となる灌流は、1980年代から施設の使用率を最大化し、プロセスの柔軟性を向上しコストを最小化する目的で実践されてきています。そして今、高度な制御ロジックを備えた新しい細胞保持装置とシングルユース技術により、実装が簡単になっています。

モダリティ別ユニット操作別製品別

Perfusion cell culture utilizes a cell retention device and continuous media exchange to achieve and maintain high cell densities and viabilities over extended periods of time. The cell retention device retains cells inside the bioreactor, while fresh media is added, and products of interest, waste products and spent (or depleted) media are continuously removed. Fresh media is provided at the same rate that product and spent media are removed from the bioreactor. Hollow fiber-based membrane filters act as the most reliable and commonly used membrane type. Long-term perfusion is typically performed in weeks.

Technology innovations, such as XCell ATF^®, solved historical challenges, shifting the paradigm towards perfusion as a key platform for modern upstream process intensification and continuous processing.

Repligen solutions help overcome key challenges in perfusion cell culture, with hands-on process and implementation consultation from global Field Applications Specialists.

専門家に相談する

Long-term Perfusion Cell Culture Workflow

Click on the workflow link below to find productivity and throughput solutions you can implement today.

Perfusion enabled 10X VCD and 10X product than Fed-Batch

Perfusion achieved 100-130 million viable cell density (VCD) compared to 13 million for Fed-Batch. Perfusion culture viability was maintained above 90% over a period of 17 days. Fed-Batch viability began to drop after day 9 to approximately 70% at days 14-15. Higher VCD and viability of perfusion cultures translated to an increase in total product yield. The perfusion process yielded approximately 30-35 g, while the Fed-Batch process achieved 3 g in approximately 15 days.